Michelle Renee Griffin - Mar 13, 2025 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role: Director
Signature: /s/ Michelle Renee Griffin by Kyle Piskel, Attorney-in-Fact
Stock symbol: ADPT
Transactions as of: Mar 13, 2025
Transactions value $: -$260,932
Form type: 4
Date filed: 3/17/2025, 07:33 PM
Previous filing: Mar 6, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ADPT	Common Stock	Sale	-$261K	-36.3K	-70.22%	$7.19	15.4K	Mar 13, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $7.15 to $7.25, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.

Content

The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $7.15 to $7.25, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.